News

2016 Nov 08

Pancreas and colon tumors reprogram the liver, causing wasting and short-circuiting body's immune response

A team led by Doug Fearon, M.D., has traced cachexia to a molecular reprogramming of the liver induced by tumors, which also releases stress hormones that can prevent the immune system from responding. Read more

2016 Nov 08

Doctors should consider physiology of obese patients when designing cancer treatment

The metabolic state of patients influences their cancer risk, progression and response to treatment, warns researchers in the lab of Meyer director Lewis Cantley. Read more

2016 Nov 08

Breast cancer awards advance efforts to address metastasis and harness immune system

Two awards from the Department of Defense will help advance research into metastasis promoting protein Bcl-xL and immune response inhibiting adenosine. Read more

2016 Nov 05

Vitamin C kills tumor cells with hard-to-treat mutation

A new study echoes the findings of the Cantley Lab regarding the potential of Vitamin C as a cancer-killing therapy. Read more

2016 Nov 04

Nachman wins national mentorship award

Professor Emeritus Ralph Nachman, M.D., has won a 2016 Mentor Award from the American Society of Hematology for his commitment to training and mentoring early-career hematologists. Read more

Heather Yeo, M.D. at work at Weill Cornell Medicine

2016 Nov 02

Why 121 years is too long to wait for gender parity in surgery

Heather Yeo, M.D., MPH, discusses the female surgeon experience and her growing role as an advocate. Read more

2016 Nov 02

National prostate biopsy and radical prostatectomy volumes decreased significantly following recommendation against PSA screening

A study by Jim Hu, M.D., and colleagues has found that the rate of prostate biopsies and radical prostatectomies decreased following a 2012 United States Preventative Task Force recommendation against prostate specific antigen (PSA) testing. Read more

2016 Nov 01

Shapeshifters in cancer

Feature about cancer resistance highlights the work of Himisha Beltran, M.D. Read more

2016 Nov 01

Pack-leading oncologist: Kristy Richards

Profile of Kristy Richards, M.D., Ph.D., and her work with lymphoma patients both canine and human. Read more

Photo of Drs. Rubin, Sboner, Beltran and Elemento

2016 Nov 01

Genomic Testing & Precision Medicine: Bigger Is Better

Olivier Elemento, Ph.D., and Mark Rubin, M.D., penned a guest piece in Oncology Times about genomics in oncology and the role of precision medicine Read more

Marcin Imielinski, M.D., Ph.D., computational biologist at Meyer Cancer Center, Weill Cornell Medicine

2016 Oct 31

API-based genomics databank facilitates personalized medicine

Personalized medicine is getting a boost at Weill Cornell Medicine with an online genomics databank that uses an API to integrate insights into the clinical workflow. Read more

2016 Oct 28

How combining an evolutionary perspective with genomic methods can advance CLL treatment

Dan Landau, M.D., Ph.D. speaks about clonal evolution in chronic lymphocytic leukemia (CLL), after his talk at the 2016 International Workshop of the German CLL Study Group in Cologne, Germany. Read more

2016 Oct 28

Research identifies new target for cancer therapy

Epichaperomes’ that form in some cancer cells might enable selective therapies, according to research from Monica Guzman, Ph.D. Read more

2016 Oct 27

White adipose tissue inflammation in early-stage breast cancer

Inflammation of white adipose tissue may be a better predictor of breast cancer incomes than body mass index, according to Andrew Dannenberg, M.D. Read more

2016 Oct 26

Ending cancer as we know it

Rohan Ramakrishna, M.D., offers his analysis of the Cancer Moonshot Task Force recommendations. Read more

2016 Oct 25

$2M gift to drive Weill Cornell advances in immunotherapy

Ellen and Gary Davis have generously made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy. Read more

2016 Oct 24

Precision medicine is more than genomic sequencing

There has been an overemphasis on the genomic component of precision medicine, according to Mark Rubin, M.D., director of the Englander Institute for Precision Medicine. Read more

2016 Oct 21

Researchers tackle metastatic breast cancer

Linda Vahdat, M.D., appeared on CBS News to discuss her novel copper depletion therapy for metastatic breast cancer. Read more

2016 Oct 20

Apostolou receives $1.5m NIH New Innovator Award

Eftychia Apostolou, Ph.D., has won a New Innovator Award from the National Institutes of Health for her research on how cells preserve their identity under normal conditions or alter it during pathogenesis Read more

2016 Oct 20

Brain surgeon chases new therapies for hard-to-treat tumors

Rohan Ramakrishna, M.D., is testing two innovative new therapies for recurrent glioblastoma and gliosarcoma. Read more

News

Pancreas and colon tumors reprogram the liver, causing wasting and short-circuiting body's immune response

Doctors should consider physiology of obese patients when designing cancer treatment

Breast cancer awards advance efforts to address metastasis and harness immune system

Vitamin C kills tumor cells with hard-to-treat mutation

Nachman wins national mentorship award

Why 121 years is too long to wait for gender parity in surgery

National prostate biopsy and radical prostatectomy volumes decreased significantly following recommendation against PSA screening

Shapeshifters in cancer

Pack-leading oncologist: Kristy Richards

Genomic Testing & Precision Medicine: Bigger Is Better

API-based genomics databank facilitates personalized medicine

How combining an evolutionary perspective with genomic methods can advance CLL treatment

Research identifies new target for cancer therapy

White adipose tissue inflammation in early-stage breast cancer

Ending cancer as we know it

$2M gift to drive Weill Cornell advances in immunotherapy

Precision medicine is more than genomic sequencing

Researchers tackle metastatic breast cancer

Apostolou receives $1.5m NIH New Innovator Award

Brain surgeon chases new therapies for hard-to-treat tumors

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters